Compare FMC Corp (FMC) vs Prologis Inc (PLD) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

PLD trades at $148.43, up 4.17% with bullish technical indicators and strong analyst support. The company reported Q1 2026 EPS of $1.05, beating estimates, and maintains robust fundamentals with $8.79B revenue and 41.54% net margin. Recent news highlights aggressive expansion into data centers and a rejected $16.9B bid for Segro, reflecting strategic growth initiatives.

Outlook remains positive with a $155.20 consensus price target and 57% buy ratings, though elevated P/E of 36.04 and rising debt-to-asset ratio to 37.2% pose valuation and leverage concerns. Key risks include integration challenges from acquisitions and macroeconomic sensitivity impacting industrial real estate demand.